Species
|
Resource
|
RRC ID
|
Title
|
Journal
|
Published
|
Link
|
Human and Animal Cells
|
TE-1(RCB1894)
,
TE-4(RCB2097)
,
TE-5(RCB1949)
,
TE-6(RCB1950)
,
TE-8(RCB2098)
,
TE-9(RCB1988)
,
TE-10(RCB2099)
,
TE-11(RCB2100)
,
TE-14(RCB2101)
,
TE-15(RCb1951)
|
78298
|
Cetuximab inhibits cisplatin-induced activation of EGFR signaling in esophageal squamous cell carcinoma.
|
Oncol Rep |
2014-9-1 |
Pubmed
Full text
|
Human and Animal Cells
|
Ehrlich(RCB0142)
|
69603
|
Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells.
|
Int J Pharm |
2010-5-31 |
Pubmed
Full text
|
Human and Animal Cells
|
HeLa/Fucci2(RCB2867)
|
63033
|
Combined effects of cisplatin and photon or proton irradiation in cultured cells: radiosensitization, patterns of cell death and cell cycle distribution.
|
J Radiat Res |
2020-11-16 |
Pubmed
Full text
|
Human and Animal Cells
|
WI-38(RCB0702)
|
60148
|
Tranilast enhances the effect of anticancer agents in osteosarcoma.
|
Oncol Rep |
2019-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HuCCT1(RCB1960)
,
TFK-1(RCB2537)
|
56026
|
Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer.
|
Cancer Res Treat |
2019-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HuCCT1(RCB1960)
,
TFK-1(RCB2537)
|
56025
|
Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer.
|
Cancer Res Treat |
2019-7-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HSC-2(RCB1945)
|
52277
|
cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
|
J Control Release |
2017-9-10 |
Pubmed
Full text
|
Human and Animal Cells
|
HuCCT1(RCB1960)
,
TFK-1(RCB2537)
|
52226
|
Sulforaphane sensitizes human cholangiocarcinoma to cisplatin via the downregulation of anti-apoptotic proteins.
|
Oncol Rep |
2017-6-1 |
Pubmed
Full text
|
Human and Animal Cells
|
HSC-2(RCB1945)
|
51689
|
Eradication of CD44-variant positive population in head and neck tumors through controlled intracellular navigation of cisplatin-loaded nanomedicines.
|
J Control Release |
2016-5-28 |
Pubmed
Full text
|
Human and Animal Cells
|
ACC-MESO-4(RCB2293)
|
45104
|
Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity.
|
BMC Cancer |
2014-4-30 |
Pubmed
Full text
|
Human and Animal Cells
|
LM8(RCB1450)
|
41642
|
Novel chondroitin sulfate-binding cationic liposomes loaded with cisplatin efficiently suppress the local growth and liver metastasis of tumor cells in vivo.
|
Cancer Res |
2002-8-1 |
Pubmed
|
Human and Animal Cells
|
RERF-LC-AI(RCB0444)
|
12435
|
Effect of treatment schedule on the interaction of Cisplatin and radiation in human lung cancer cells.
|
Radiat Res |
2007-6-1 |
Pubmed
Full text
|